Dyslipidemia
Also known as: Hyperlipidemia · Mixed Lipid Disorder
Dyslipidemia is abnormal circulating lipids — elevated LDL or non-HDL cholesterol, elevated triglycerides, low HDL, or elevated ApoB — that drive atherosclerotic cardiovascular disease risk.
What you need to know
Provider-reviewed lipid optimization interprets the full panel (LDL, HDL, triglycerides, ApoB, non-HDL, lipoprotein(a)) in context of global cardiovascular risk, family history, and metabolic state. Therapy decisions are individualized; lifestyle and lipid-directed medication are complementary.
How this entity relates
Every entity in the oMeds knowledge graph cross-links to the conditions, biomarkers, medications, and educational surfaces it touches.
Bring this entity into your optimization pathway
Every condition, symptom, biomarker, and medication on oMeds is reviewed by a licensed provider and recalibrated against the standardized biomarker panel.